MIRROR: Mirikizumab Real World Protocol (clinicaltrials.gov) - Sep 24, 2026 - P=N/A | N=6 | Terminated | Sponsor: University of North Carolina, Chapel Hill | N=100 ➔ 6 | Trial completion date: Jan 2030 ➔ Jul 2026 | Recruiting ➔ Terminated | Trial primary completion date: Jan 2030 ➔ Jul 2026; Poor accrual
Enrollment change • Real-world evidence • Trial completion date • Trial primary completion date • Trial termination • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
|